Acadia Pharmaceuticals

ACAD

28.00

-0.25

-0.9%

After Hours:

28.00

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 28.38
Prev. Close: 28.25
Low/Hi: 27.79 - 28.58
52-Week: 24.31 - 41.20
Volumes
Equity: 469,439
90-Day Avg: 1,501,736
Option: 517
90-Day Avg: 1,846
Volatility
Todays Stock Vol: 25.5
20-Day (HV): 38.8
52-Week (HV): 44.2
30-Day IV: 50.6 -1.8
IV Pct Rank: 25% Subdued
Fundamental
Div. Yield:
Earnings: 1-Mar (Est.)
P/E Ratio:
Market Cap: 3.5 B
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

ACAD Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Sep-2017 30-Jun-2017 31-Mar-2017 31-Dec-2016
Net Income -65,248 -36,966 -87,843 -78,696
Change in Working Capital -13,707 -10,195 1,085 111
Depreciation Amortization Depletion and Accretion 856 492 526 574
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 19,698 18,244 15,571 14,822
Total Cash from Operating Activities -58,401 -58,900 -70,661 -63,189
Capital Expenditures -56 -264 -485 -249
Other Investing Cash Flow 19,388 38,563 53,420 69,389
Total Cash from Investing Activities 19,332 38,299 52,935 69,140
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 7,897 7,010 11,490 3,390
Purchase and Retirement of Debt 0 0 0 0
Other Financing Cash Flow 0 0 0 596
Total Cash from Financing Activities 7,897 7,010 11,490 3,986
Exchange Rate Effects -1 -3 -1 4
Net Change in Cash -31,173 -13,594 -6,237 9,941
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Net Income -271,393 -164,443 -92,475 -37,948
Change in Working Capital 4,394 4,114 9,312 -1,129
Depreciation Amortization Depletion and Accretion 1,917 -1,413 690 1,607
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 54,674 39,947 16,039 5,701
Total Cash from Operating Activities -210,408 -121,795 -66,434 -31,769
Capital Expenditures -9,506 -2,141 -180 -618
Other Investing Cash Flow -252,418 149,711 -87,093 -125,486
Total Cash from Investing Activities -261,924 147,570 -87,273 -126,104
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 533,216 14,547 203,851 111,682
Purchase and Retirement of Debt 0 0 0 0
Other Financing Cash Flow 596 -45 0 0
Total Cash from Financing Activities 533,812 14,502 203,851 111,682
Exchange Rate Effects 2 7 3 -1
Net Change in Cash 61,482 40,284 50,147 -46,192